Fig. 5From: Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathwayZeb-1 was essential for inhibition of EMT by OGN. a Cells with OGN over-expression were challenged with EGF (100 ng/mL) and transiently transfected with Zeb-1. Western blotting with the significantly altered markers was performed. b Wound healing assay and (c), cell invasion assay. The results are expressed as the mean ± SD of three independent experimentsBack to article page